These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26629040)

  • 1. ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway.
    Zhao QY; Ju F; Wang ZH; Ma XZ; Zhao H
    Int J Clin Exp Med; 2015; 8(9):15498-505. PubMed ID: 26629040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways.
    Liu XL; Zhang XT; Meng J; Zhang HF; Zhao Y; Li C; Sun Y; Mei QB; Zhang F; Zhang T
    Oncotarget; 2017 Aug; 8(33):54265-54276. PubMed ID: 28903339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway.
    Gao W; Han J
    Biomed Pharmacother; 2018 Feb; 98():265-270. PubMed ID: 29272787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway.
    Wang Y; Tan J; Li J; Chen H; Wang W
    Technol Cancer Res Treat; 2021; 20():15330338211039940. PubMed ID: 34520285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ING5 suppresses breast cancer progression and is regulated by miR-24.
    Cui S; Liao X; Ye C; Yin X; Liu M; Hong Y; Yu M; Liu Y; Liang H; Zhang CY; Chen X
    Mol Cancer; 2017 May; 16(1):89. PubMed ID: 28490335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
    Zhang GJ; Zhao J; Jiang ML; Zhang LC
    Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy.
    Ding XQ; Zhao S; Yang L; Zhao X; Zhao GF; Zhao SP; Li ZJ; Zheng HC
    Oncotarget; 2017 Oct; 8(47):81953-81966. PubMed ID: 29137236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of ING5 expression in ovarian carcinogenesis and subsequent progression: a target of gene therapy.
    Zheng HC; Zhao S; Song Y; Ding XQ
    Oncotarget; 2017 Nov; 8(61):103449-103464. PubMed ID: 29262575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy.
    Zhao S; Zhao ZJ; He HY; Wu JC; Ding XQ; Yang L; Jia N; Li ZJ; Zheng HC
    Oncotarget; 2017 Aug; 8(34):56558-56568. PubMed ID: 28915612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
    Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
    Wang Y; Liu C; Xie Z; Lu H
    Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
    J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway.
    Lu L; Chen G; Yang J; Ma Z; Yang Y; Hu Y; Lu Y; Cao Z; Wang Y; Wang X
    Biomed Pharmacother; 2019 Apr; 112():108625. PubMed ID: 30784920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ING5 differentially regulates protein lysine acetylation and promotes p300 autoacetylation.
    Zhang T; Meng J; Liu X; Zhang X; Peng X; Cheng Z; Zhang F
    Oncotarget; 2018 Jan; 9(2):1617-1629. PubMed ID: 29416718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.